Johnson & Johnson Statistics
Total Valuation
JNJ has a market cap or net worth of $491.26 billion. The enterprise value is $518.49 billion.
| Market Cap | 491.26B |
| Enterprise Value | 518.49B |
Important Dates
The last earnings date was Tuesday, October 14, 2025, before market open.
| Earnings Date | Oct 14, 2025 |
| Ex-Dividend Date | Nov 25, 2025 |
Share Statistics
JNJ has 2.41 billion shares outstanding. The number of shares has decreased by -0.17% in one year.
| Current Share Class | 2.41B |
| Shares Outstanding | 2.41B |
| Shares Change (YoY) | -0.17% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 74.34% |
| Float | 2.41B |
Valuation Ratios
The trailing PE ratio is 19.70 and the forward PE ratio is 18.29. JNJ's PEG ratio is 2.70.
| PE Ratio | 19.70 |
| Forward PE | 18.29 |
| PS Ratio | 5.33 |
| Forward PS | 5.01 |
| PB Ratio | 6.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.07 |
| P/OCF Ratio | 20.30 |
| PEG Ratio | 2.70 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.24, with an EV/FCF ratio of 26.46.
| EV / Earnings | 20.64 |
| EV / Sales | 5.63 |
| EV / EBITDA | 16.24 |
| EV / EBIT | 21.13 |
| EV / FCF | 26.46 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.58.
| Current Ratio | 1.07 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 1.43 |
| Debt / FCF | 2.34 |
| Interest Coverage | 27.44 |
Financial Efficiency
Return on equity (ROE) is 33.62% and return on invested capital (ROIC) is 13.28%.
| Return on Equity (ROE) | 33.62% |
| Return on Assets (ROA) | 8.26% |
| Return on Invested Capital (ROIC) | 13.28% |
| Return on Capital Employed (ROCE) | 17.28% |
| Revenue Per Employee | $667,263 |
| Profits Per Employee | $181,890 |
| Employee Count | 138,100 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.18 |
Taxes
In the past 12 months, JNJ has paid $6.38 billion in taxes.
| Income Tax | 6.38B |
| Effective Tax Rate | 20.26% |
Stock Price Statistics
The stock price has increased by +33.17% in the last 52 weeks. The beta is 0.36, so JNJ's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +33.17% |
| 50-Day Moving Average | 188.27 |
| 200-Day Moving Average | 168.06 |
| Relative Strength Index (RSI) | 79.76 |
| Average Volume (20 Days) | 8,925,652 |
Short Selling Information
The latest short interest is 19.53 million, so 0.81% of the outstanding shares have been sold short.
| Short Interest | 19.53M |
| Short Previous Month | 18.18M |
| Short % of Shares Out | 0.81% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, JNJ had revenue of $92.15 billion and earned $25.12 billion in profits. Earnings per share was $10.35.
| Revenue | 92.15B |
| Gross Profit | 62.99B |
| Operating Income | 24.53B |
| Pretax Income | 31.50B |
| Net Income | 25.12B |
| EBITDA | 31.92B |
| EBIT | 24.53B |
| Earnings Per Share (EPS) | $10.35 |
Balance Sheet
The company has $18.56 billion in cash and $45.80 billion in debt, giving a net cash position of -$27.23 billion or -$11.30 per share.
| Cash & Cash Equivalents | 18.56B |
| Total Debt | 45.80B |
| Net Cash | -27.23B |
| Net Cash Per Share | -$11.30 |
| Equity (Book Value) | 79.28B |
| Book Value Per Share | 32.95 |
| Working Capital | 3.74B |
Cash Flow
In the last 12 months, operating cash flow was $24.20 billion and capital expenditures -$4.61 billion, giving a free cash flow of $19.60 billion.
| Operating Cash Flow | 24.20B |
| Capital Expenditures | -4.61B |
| Free Cash Flow | 19.60B |
| FCF Per Share | $8.13 |
Margins
Gross margin is 68.35%, with operating and profit margins of 26.62% and 27.26%.
| Gross Margin | 68.35% |
| Operating Margin | 26.62% |
| Pretax Margin | 34.19% |
| Profit Margin | 27.26% |
| EBITDA Margin | 34.64% |
| EBIT Margin | 26.62% |
| FCF Margin | 21.27% |
Dividends & Yields
This stock pays an annual dividend of $5.20, which amounts to a dividend yield of 2.55%.
| Dividend Per Share | $5.20 |
| Dividend Yield | 2.55% |
| Dividend Growth (YoY) | 4.68% |
| Years of Dividend Growth | 63 |
| Payout Ratio | 49.67% |
| Buyback Yield | 0.17% |
| Shareholder Yield | 2.72% |
| Earnings Yield | 5.11% |
| FCF Yield | 3.99% |
Analyst Forecast
The average price target for JNJ is $196.60, which is -3.58% lower than the current price. The consensus rating is "Buy".
| Price Target | $196.60 |
| Price Target Difference | -3.58% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 5.49% |
| EPS Growth Forecast (5Y) | 20.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 13, 2001. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 13, 2001 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
JNJ has an Altman Z-Score of 4.16 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.16 |
| Piotroski F-Score | 4 |